(+/-)-6-(benzo[b]thiophen-2-yl)-5,6-dihydroimidazo[2,1-b]thiazole hydrochloride

ID: ALA3092295

PubChem CID: 72737028

Max Phase: Preclinical

Molecular Formula: C13H11ClN2S2

Molecular Weight: 258.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C1=CN2CC(c3cc4ccccc4s3)N=C2S1.Cl

Standard InChI:  InChI=1S/C13H10N2S2.ClH/c1-2-4-11-9(3-1)7-12(17-11)10-8-15-5-6-16-13(15)14-10;/h1-7,10H,8H2;1H

Standard InChI Key:  VAMVMXMVUABESY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   14.6363   -3.5473    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   13.1838   -4.9868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4109   -4.7302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1848   -5.8186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9207   -5.3963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3968   -6.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9717   -4.7363    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.0950   -5.3989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9695   -6.0712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4598   -5.4051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6080   -4.7330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6122   -6.0689    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.8261   -5.8164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8247   -4.9933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1125   -4.5849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4011   -4.9983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4065   -5.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1194   -6.2291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  2  0
  4  2  1  0
  5  3  1  0
  6  4  1  0
  7  2  1  0
  5  8  1  0
  9  4  1  0
 10  7  1  0
 10  9  2  0
  6  5  1  0
  8 11  2  0
 11 14  1  0
 13 12  1  0
 12  8  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END

Associated Targets(Human)

SAOS-2 (672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MG-63 (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALPI Tchem Intestinal alkaline phosphatase (724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALPP Tbio Alkaline phosphatase placental type (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 258.37Molecular Weight (Monoisotopic): 258.0285AlogP: 3.83#Rotatable Bonds: 1
Polar Surface Area: 15.60Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.10CX LogP: 3.31CX LogD: 3.31
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.77Np Likeness Score: -0.97

References

1. Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M..  (2013)  Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests.,  21  (24): [PMID:24183741] [10.1016/j.bmc.2013.09.053]

Source